Prostate International

Papers
(The TQCC of Prostate International is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization52
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer35
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship21
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy19
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer19
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification18
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey18
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study18
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study17
Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects17
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis16
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study16
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign 15
Holmium laser enucleation of the prostate as a treatment option for patients with concurrent outlet obstruction and bladder diverticulum15
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis13
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients13
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre13
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures12
Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data12
Transurethral water vapor therapy (Rezūm) for acute urinary retention with obstructive uropathy: a prospective cohort study with one-year follow-up12
Evaluation of the efficiency of transurethral enucleation with bipolar energy according to prostate volume for patients with benign prostate hyperplasia12
The prevalence of dyslipidemia in patients with prostate cancer12
Assessing the influence of prostate tissue traits on Gallium-68 prostate-specific membrane-antigen positron-emission tomography/computed tomography: predictive factors for image positivity and locoreg11
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer11
Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg11
Time to castrate the cost? the rising expense of chemical castration for the management of prostate cancer11
Comparing the efficacy of tadalafil and tamsulosin for managing erectile dysfunction and lower urinary tract symptoms in prostate brachytherapy patients: a prospective study10
Clinical implication of peri-seminal vesicle soft-tissue invasion in patients with pT3b prostate cancer10
Comparative study of open versus robotic radical prostatectomy in Renal Transplant Recipients and review of the literature10
Efficacy and safety of pentosan polysulfate therapy in patients with interstitial cystitis for relief of lower urinary tract symptoms: 15-year single center experience10
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia10
The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension10
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer9
Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study9
Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: Short-term follow-up results9
Oncologic outcomes of salvage radiotherapy and lymphadenectomy for positron emission tomography–positive lymph nodes in biochemical recurrence: A systematic review to inform treatment decisions8
A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation8
Irreversible electroporation for prostate cancer using PSMA PET-CT8
Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)8
Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings8
Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis8
High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group8
Single-port and multiport robot-assisted radical prostatectomy: A meta-analysis8
Utilization of prostate-specific membrane antigen positron emission tomography in Australia following government subsidization: Trends in primary staging and biochemical recurrence7
Application of robotics in the treatment of benign prostatic hyperplasia: a narrative review7
Prostate diseases and microbiome in the prostate, gut, and urine7
A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant prostate cancer in targeted biopsies: lesion density7
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study7
Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system7
Preoperative prostatic artery embolization before transurethral resection of the prostate for prostate glands larger than 80 mL: the first randomized controlled trial7
0.042497873306274